menu ☰
menu ˟

Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis

23 Jun 2016

Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). The aim of this study was to explore the safety and efficacy of open-label tofacitinib following blinded treatment ...

Click here to view the full article which appeared in Arthritis Research & Therapy